Multichannel
How sustainable is remote health at scale?
Remote health has proved its worth to the entire healthcare sector but sustaining and scaling it requires work from every stakeholder
Multichannel
How sustainable is remote health at scale?
With the crisis in healthcare resulting from COVID-19 also come opportunities. One of these opportunities is the mass...
Patients and Medical
Racially diverse clinical trials: A new patient-led legacy takes root
The differing health outcomes from COVID-19, depending on sufferers’ ethnic background, is a salutary reminder of the uneven, and...
Latest
-
-
Patients and Medical
Digital companions: helping improve patient treatment journeys
The virtual health explosion isn't going away. This just at the start of an era of digital enhancement -
Patients and Medical
Racially diverse clinical trials: A new patient-led legacy takes root
Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities -
Patients and Medical
Patient engagement: Breaking through in digital
The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential -
Commercial
Adapting to the multichannel imperative: A special report
Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales.
Most Popular
Nicola Davies, (Sep 4, 2020)
View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Lucy Fulford, (Sep 16, 2020)
Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets
Andrew Stone, (Sep 16, 2020)
Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
Opinion
Jill Donahue, (Oct 2, 2020)
Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's power to do good
Jill Donahue, (Apr 14, 2020)
Merck's Thomas D’Hooghe shares his thoughts on passion, purpose, leading people and making a difference
Commercial
-
Adapting to the multichannel imperative: A special report
Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales. -
Australia’s field force: evolving on fast forward
Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets -
Customer centricity in a changed world
Pharma’s marketeers are having to rapidly change their approach to customers, field force roles and digital in the midst of the pandemic -
The changing nature of pharma sales: A conversation on many levels
The new approach to sales marries state of the art analytics with a classical approach to engagement -
Time to embrace social media
Patients are turning to social media as never before and pharma needs to catch up
Access and Evidence
-
A burning desire to make a difference for patients
Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients -
From reactive to predictive: Concerto’s new compositions
Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton -
Evolving HTA frameworks to accelerate innovation
Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague -
Can we afford to pay for future cures?
Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging -
Advancing RWE together with academia
Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
Patients and Medical
-
Digital companions: helping improve patient treatment journeys
The virtual health explosion isn't going away. This just at the start of an era of digital enhancement -
Racially diverse clinical trials: A new patient-led legacy takes root
Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities -
Patient engagement: Breaking through in digital
The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential -
Amplifying the patient voice in rare disease access
Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom -
From complexity to clarity in cell and gene therapy
Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
Latest Videos
Upcoming events
View All EventsNovember 2020
December 2020
-
Pharma & Patient Summit USA Virtual
Dec 1, 2020 - Dec 4, 2020
Digital Conference, Networking & Exhibition
-
Pharma Awards USA
Dec 2, 2020 - Dec 2, 2020
May 2021
October 2021
-
Pharma Europe 2021
Oct 12, 2021 - Oct 13, 2021